Rongtao T. Lai

197 Ruijin Er Road
Huangpu, 200025, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

An Efferocytosis-Associated Gene Signature for Identifying At-Risk MASH: Transcriptomic and Exploratory Plasma Biomarker Assessment.

An Efferocytosis-Associated Gene Signature for Identifying At-Risk MASH: Transcriptomic and Exploratory Plasma Biomarker Assessment.

Journal: Genes

Published: June 11, 2026

Proteomic Analysis Reveals That P97 Inhibitors Induce Ferroptosis in Gastric Cancer AGS Cells.

Proteomic Analysis Reveals That P97 Inhibitors Induce Ferroptosis in Gastric Cancer AGS Cells.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 05, 2026

Synergistic Effects of Type 2 Diabetes and Alcohol on All-Cause and Liver-Related Mortality in Steatotic Liver Disease.

Synergistic Effects of Type 2 Diabetes and Alcohol on All-Cause and Liver-Related Mortality in Steatotic Liver Disease.

Journal: Alimentary pharmacology & therapeutics

Published: January 13, 2026

Non-varicose gastrointestinal bleeding: an overlooked cause of bleeding in porto-sinusoidal vascular liver disorder.

Non-varicose gastrointestinal bleeding: an overlooked cause of bleeding in porto-sinusoidal vascular liver disorder.

Journal: Gastroenterology report

Published: June 04, 2025

Machine learning models based on adipocyte fatty acid-binding protein help predict the chronic and lethal outcomes of patients with drug-induced liver injury.

Machine learning models based on adipocyte fatty acid-binding protein help predict the chronic and lethal outcomes of patients with drug-induced liver injury.

Journal: Postgraduate medical journal

Published: May 08, 2025

Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study.

Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study.

Journal: Clinical and molecular hepatology

Published: December 05, 2024

Enhanced long-term outcomes with laparoscopic bariatric surgery in patients with severe obesity and metabolic dysfunction-associated steatotic liver disease: a retrospective cohort study.

Enhanced long-term outcomes with laparoscopic bariatric surgery in patients with severe obesity and metabolic dysfunction-associated steatotic liver disease: a retrospective cohort study.

Journal: Hepatobiliary surgery and nutrition

Published: September 20, 2024

Incidence rates of hepatocellular carcinoma based on risk stratification in steatotic liver disease for precision medicine: A real-world longitudinal nationwide study.

Incidence rates of hepatocellular carcinoma based on risk stratification in steatotic liver disease for precision medicine: A real-world longitudinal nationwide study.

Journal: PLoS medicine

Published: April 30, 2024

Synergistic association of sodium-glucose cotransporter-2 inhibitor and metformin on liver and non-liver complications in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease.

Synergistic association of sodium-glucose cotransporter-2 inhibitor and metformin on liver and non-liver complications in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease.

Journal: Gut

Published: March 20, 2024

Drug-induced liver injury in children: A nationwide cohort study from China.

Drug-induced liver injury in children: A nationwide cohort study from China.

Journal: JHEP reports : innovation in hepatology

Published: November 08, 2023

Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update.

Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update.

Journal: Hepatology international

Published: October 07, 2023

Clinic-radiomics model using liver magnetic resonance imaging helps predict chronicity of drug-induced liver injury.

Clinic-radiomics model using liver magnetic resonance imaging helps predict chronicity of drug-induced liver injury.

Journal: Hepatology international

Published: March 14, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026